Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Amedisys Inc.

    NASDAQ: AMED · Real-Time Price · USD
    97.81
    0.16 (0.16%)
    At close: Jun 25, 2025, 11:33 AM

    Amedisys Statistics

    Share Statistics

    Amedisys has 32.82M shares outstanding. The number of shares has increased by 0.41% in one year.

    Shares Outstanding

    n/a
    		 32.82M

    Shares Change (YoY)

    n/a
    		 0.41%

    Shares Change (QoQ)

    n/a
    		 0.17%

    Owned by Institutions (%)

    n/a
    		 91.47%

    Shares Floating

    n/a
    		 31.92M

    Failed to Deliver (FTD) Shares

    n/a
    		 1

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 1.88M, so 5.72% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 1.88M

    Short % of Shares Out

    n/a
    		 5.72%

    Short % of Float

    n/a
    		 5.82%

    Short Ratio (days to cover)

    n/a
    		 8.59

    Valuation Ratios

    The PE ratio is 68.71 and the forward PE ratio is 19.07. Amedisys's PEG ratio is -0.13.

    PE Ratio

    n/a
    		 68.71

    Forward PE

    n/a
    		 19.07

    PS Ratio

    n/a
    		 1.26

    Forward PS

    n/a
    		 1.2

    PB Ratio

    n/a
    		 2.62

    P/FCF Ratio

    n/a
    		 13.81

    PEG Ratio

    n/a
    		 -0.13
    Financial Ratio History

    Enterprise Valuation

    Amedisys has an Enterprise Value (EV) of 3.13B.

    EV / Sales

    n/a
    		 1.33

    EV / EBITDA

    n/a
    		 42.58

    EV / EBIT

    n/a
    		 14.11

    EV / FCF

    n/a
    		 14.54

    Financial Position

    The company has a current ratio of 1.23, with a Debt / Equity ratio of 0.41.

    Current Ratio

    n/a
    		 1.23

    Quick Ratio

    n/a
    		 1.23

    Debt / Equity

    n/a
    		 0.41

    Debt / EBITDA

    n/a
    		 6.27

    Debt / FCF

    n/a
    		 2.14

    Interest Coverage

    n/a
    		 3.07

    Financial Efficiency

    Return on Equity is 3.81% and Return on Invested Capital is 2.48%.

    Return on Equity

    n/a
    		 3.81%

    Return on Assets

    n/a
    		 2.02%

    Return on Invested Capital

    n/a
    		 2.48%

    Revenue Per Employee

    n/a
    		 $123,596

    Profits Per Employee

    n/a
    		 $2,275.32

    Employee Count

    n/a
    		 19,000

    Asset Turnover

    n/a
    		 1.1

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 48.05M

    Effective Tax Rate

    n/a
    		 55.74%

    Stock Price Statistics

    The stock price has increased by 6.01% in the last 52 weeks. The beta is 0.94, so Amedisys's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.94

    52-Week Price Change

    n/a
    		 6.01%

    50-Day Moving Average

    n/a
    		 94.73

    200-Day Moving Average

    n/a
    		 93.15

    Relative Strength Index (RSI)

    n/a
    		 67.82

    Average Volume (20 Days)

    n/a
    		 360,100

    Income Statement

    In the last 12 months, Amedisys had revenue of 2.35B and earned 43.23M in profits. Earnings per share was 1.32.

    Revenue

    n/a
    		 2.35B

    Gross Profit

    n/a
    		 1.02B

    Operating Income

    n/a
    		 94.54M

    Net Income

    n/a
    		 43.23M

    EBITDA

    n/a
    		 73.45M

    EBIT

    n/a
    		 55.45M

    Earnings Per Share (EPS)

    n/a
    		 1.32
    Full Income Statement

    Balance Sheet

    The company has 303.24M in cash and 460.18M in debt, giving a net cash position of -156.94M.

    Cash & Cash Equivalents

    n/a
    		 303.24M

    Total Debt

    n/a
    		 460.18M

    Net Cash

    n/a
    		 -156.94M

    Retained Earnings

    n/a
    		 791.16M

    Total Assets

    n/a
    		 2.18B

    Working Capital

    n/a
    		 141.93M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 221.66M and capital expenditures -6.55M, giving a free cash flow of 215.12M.

    Operating Cash Flow

    n/a
    		 221.66M

    Capital Expenditures

    n/a
    		 -6.55M

    Free Cash Flow

    n/a
    		 215.12M

    FCF Per Share

    n/a
    		 6.57
    Full Cash Flow Statement

    Margins

    Gross margin is 43.34%, with operating and profit margins of 4.03% and 1.84%.

    Gross Margin

    n/a
    		 43.34%

    Operating Margin

    n/a
    		 4.03%

    Pretax Margin

    n/a
    		 3.67%

    Profit Margin

    n/a
    		 1.84%

    EBITDA Margin

    n/a
    		 3.13%

    EBIT Margin

    n/a
    		 4.03%

    FCF Margin

    n/a
    		 9.16%

    Dividends & Yields

    AMED does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 1.46%

    FCF Yield

    n/a
    		 7.24%
    Dividend Details

    Analyst Forecast

    The average price target for AMED is $101, which is 3.4% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $101

    Price Target Difference

    n/a
    		 3.4%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 5
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 $6.6

    Lynch Upside

    n/a
    		 -93.24%

    Graham Number

    n/a
    		 32.11

    Graham Upside

    n/a
    		 -67.12%

    Stock Splits

    The last stock split was on Dec 5, 2006. It was a forward split with a ratio of 4:3.

    Last Split Date

    n/a
    		 Dec 5, 2006

    Split Type

    n/a
    		 forward

    Split Ratio

    n/a
    		 4:3

    Scores

    Altman Z-Score

    n/a
    		 3.91

    Piotroski F-Score

    n/a
    		 8

    Add to Watchlist